| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.06B | 1.14B | 934.60M | 1.14B | 882.50M | 587.10M |
| Gross Profit | 664.80M | 718.10M | 780.70M | 701.70M | 518.11M | 535.48M |
| EBITDA | 783.30M | 874.80M | 782.70M | 872.10M | 657.20M | 524.20M |
| Net Income | 464.10M | 524.60M | 433.60M | 469.70M | 404.90M | 365.30M |
Balance Sheet | ||||||
| Total Assets | 3.96B | 3.99B | 3.85B | 3.94B | 3.85B | 4.58B |
| Cash, Cash Equivalents and Short-Term Investments | 388.40M | 384.50M | 186.70M | 418.30M | 340.85M | 239.35M |
| Total Debt | 1.52B | 1.63B | 1.82B | 2.16B | 2.22B | 3.25B |
| Total Liabilities | 2.09B | 2.21B | 2.33B | 2.65B | 2.91B | 3.59B |
| Stockholders Equity | 1.86B | 1.79B | 1.51B | 1.29B | 938.54M | 997.70M |
Cash Flow | ||||||
| Free Cash Flow | 535.60M | 463.30M | 423.10M | 405.80M | 423.25M | 163.59M |
| Operating Cash Flow | 681.40M | 577.50M | 559.50M | 504.70M | 453.64M | 328.68M |
| Investing Cash Flow | 55.20M | -114.20M | 36.10M | -273.50M | 982.04M | -241.82M |
| Financing Cash Flow | -467.40M | -441.20M | -588.90M | -429.10M | -1.29B | -187.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | 20.03B | 12.63 | 24.33% | 4.24% | -15.01% | -16.12% | |
77 Outperform | $5.28B | 10.97 | 28.23% | 8.54% | -8.84% | -0.14% | |
76 Outperform | $16.33B | 17.52 | 10.26% | 5.85% | 18.62% | -18.29% | |
68 Neutral | 3.36B | 19.28 | ― | 6.67% | 11.84% | -4.96% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
44 Neutral | 14.15B | ― | ― | ― | -26.31% | -655.28% |
NewMed Energy Limited Partnership is a company engaged in the exploration, development, production, and marketing of natural gas, condensate, and oil, primarily operating in Israel, Cyprus, Bulgaria, and Morocco, with interests in renewable energy projects.
NewMed Energy Limited Partnership is a company primarily engaged in the exploration, development, production, and marketing of natural gas, condensate, and oil, operating in Israel, Cyprus, Bulgaria, and Morocco, with a focus on increasing natural gas sales and exploring renewable energy opportunities. In its latest earnings report, NewMed Energy announced a profit distribution of $60 million and highlighted the impact of military operations in Q2 2025, which led to a temporary halt in natural gas production from the Leviathan reservoir. The company’s comprehensive income for the period was $197.4 million, a decrease of 23.5% compared to the previous year, mainly due to reduced revenues from natural gas and condensate sales. Despite the challenges, NewMed Energy continued to secure new agreements for natural gas supply, including deals with Jordan and Egypt, and maintained its credit ratings, reflecting resilience amid geopolitical tensions. Looking forward, the company remains focused on resuming full production and exploring additional opportunities in renewable energy and hydrogen projects, while navigating the uncertainties posed by regional conflicts.